Wall Street Journal  4 hrs ago  Comment 
Federal courts have rejected more software patents since a U.S. Supreme Court ruling in June tackled the question of whether—and when—computer programs can qualify for intellectual-property protection.
The Hindu Business Line  Sep 19  Comment 
Concessions will disarm India in its pursuit of the right to health
SeekingAlpha  Sep 19  Comment 
By Boris Marjanovic: Business Overview RPX's (NASDAQ:RPXC) core business is defensive patent aggregation which helps reduce patent assertion and litigation initiated by "patent trolls" or more commonly referred to as "non-practicing entities"...
SeekingAlpha  Sep 19  Comment 
By Alpha Exposure: We believe that the most important thing for the CEO of VirnetX (AMEX: VHC) to address during his "fireside" chat on September 19th is the current status of the ongoing inter partes reexaminations of the patents that are at the...
SeekingAlpha  Sep 18  Comment 
By Lisa Thompson: Finjan (NASDAQ:FNJN), has been restructured to become a cybersecurity licensing entity using patents it developed starting in the late 90s. Despite its limited track record in licensing, we believe it could be successful in...
Motley Fool  Sep 17  Comment 
VirnetX shares fell 60% on Tuesday as a federal court slapped a big patent case back to another court to reconsider damages. Is the tide turning against overly ambitious patent managers?
The Hindu Business Line  Sep 17  Comment 
A federal appeals court Tuesday tossed out a $368 million verdict against Apple, ruling that jurors were given evidence that may have skewed the sum. “We vacate the jury’s damages award a...
Wall Street Journal  Sep 16  Comment 
A federal appeals court on Tuesday threw out a $368 million jury award for patent infringement that VirnetX Holding Corp. won against Apple Inc. in 2012.
DailyFinance  Sep 16  Comment 
MOBOTIX Corp., New York, prevailed again in a patent dispute with San Antonio, Texas-based e-Watch Inc. The U.S. Patent and Trademark Office (USPTO) granted MOBOTIX Corp.’s request and determined that all claims of U.S. Pat....
DailyFinance  Sep 16  Comment 
REDWOOD SHORES, CA -- (Marketwired) -- 09/16/14 -- Saba (OTCPink: SABA), the leader in cloud-based Intelligent Talent Management, today announced that it has secured three new patents in the areas of social network influence analysis, offline...



Patent is the right to ownership,as part of an intellectual property law, where by a person / organization discovers a lesser known concept or invents something new and holds sole intellectual ownership rights to that particular idea. These are usually published / granted after a lot of research and exhaustive verification. Patents are generally registered with United States Patent and Trademark Office, an Agency Of The United States Department Of Commerce, in the United States and The Intellectual Property Office,a division of the Department for Innovation, Universities & Skills in the United Kingdom.

Technological Patents

Pharmaceutical Patents

Pharmaceutical patents protect manufacturers of prescription drugs, prohibiting others from producing a drug during the length of its patent protection. The length of these patents varies in different countries, though they are usually between 15-20 years. In the U.S., a pharmaceutical patent is valid for 20 years. Drug companies usually apply for patent protection before they actually begin producing the drug, opting instead to secure their rights to a particular compound at the beginning of the testing process. By the time a drug comes to market, there may only be 8-10 years of patent protection remaining, which is significantly less than the 20 offered by the patent. Companies often attempt to extend these patents by making slight reformulations of the original compound or proving its effectiveness at treating a condition other than the one for which it was originally granted a patent. This is referred to as "evergreening", a practice which many criticize.

For further information on the process of obtaining pharmaceutical patents and regulatory approval, see Clinical Trials and FDA Approval.

For more information about pharmaceutical patents in relation to generic versions of drugs, see Generic Drugs.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki